ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

ROS regulation in gliomas: implications for treatment strategies

Yang, Yu-Chen; Zhu, Yu; Sun, Si-Jia; Zhao, Can-Jun; Bai, Yang*; Wang, Jin*; Ma, Li-Tian*东莞理工学院; 广州中医药大学; 中国人民解放军第四军医大学; y
Frontiers in Immunology2023-12-7DOI: 10.3389/fimmu.2023.1259797
6阅读
引用收藏
分享

摘要

Gliomas are one of the most common primary malignant tumours of the central nervous system (CNS), of which glioblastomas (GBMs) are the most common and destructive type. The glioma tumour microenvironment (TME) has unique characteristics, such as hypoxia, the blood-brain barrier (BBB), reactive oxygen species (ROS) and tumour neovascularization. Therefore, the traditional treatment effect is limited. As cellular oxidative metabolites, ROS not only promote the occurrence and development of gliomas but also affect immune cells in the immune microenvironment. In contrast, either too high or too low ROS levels are detrimental to the survival of glioma cells, which indicates the threshold of ROS. Therefore, an in-depth understanding of the mechanisms of ROS production and scavenging, the threshold of ROS, and the role of ROS in the glioma TME can provide new methods and strategies for glioma treatment. Current methods to increase ROS include photodynamic therapy (PDT), sonodynamic therapy (SDT), and chemodynamic therapy (CDT), etc., and methods to eliminate ROS include the ingestion of antioxidants. Increasing/scavenging ROS is potentially applicable treatment, and further studies will help to provide more effective strategies for glioma treatment.

学科与关键词

关键词
gliomaROStumor microenvironmentantioxidantsphotodynamic therapysonodynamic therapychemodynamic therapynanodrug delivery platforms
相关
加载中…
  • Photodynamic therapy enhances the cytotoxicity of temozolomide against glioblastoma via reprogramming anaerobic glycolysis
    Li, Yongzhe; Wang, Dan; Zhang, Zhaoxia; Wang, Yunzhi; Zhang, Zichen; Liang, Zibin*; Liu, Fei*; Chen, Lei*Photodiagnosis and Photodynamic Therapy, 2023, 42: 103342.被引 1
  • The immunosuppressive microenvironment and immunotherapy in human glioblastoma
    Zhang, Xuehua; Zhao, Leilei; Zhang, He; Zhang, Yurui; Ju, Huanyu; Wang, Xiaoyu; Ren, Huan*; Zhu, Xiao*; Dong, Yucui*Frontiers in Immunology, 2022, 13: 1003651.被引 6
  • Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives
    Guo, Qing-Long; Dai, Xing-Liang; Yin, Meng-Yuan; Cheng, Hong-Wei*; Qian, Hai-Sheng; Wang, Hua; Zhu, Dao-Ming*; Wang, Xian-Wen*Military Medical Research, 2022, 9(1): 26.被引 41
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2023-12-07
卷期
第 14 卷
页码
1259797
DOI
10.3389/fimmu.2023.1259797
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82101318]; Social Talent Fund Funding Program Project [2021SHRC044]; Scientific Research Project Book of Traditional Chinese Medicine Administration of Shaanxi Province [SZY-KJCYC-2023-003]; Special Fund for the Cultivation and Enhancement of Military Traditional Chinese Medicine Service Capabilities [2021ZY021]

作者

  • Y

    Yang, Yu-Chen (第一作者)

    fourth mil med univ

  • Z

    Zhu, Yu

    dongguan polytech · 2 · guangzhou univ chinese med

查看全部 7 位作者收起作者
  • S

    Sun, Si-Jia

    xian med univ

  • Z

    Zhao, Can-Jun

    fourth mil med univ

  • B

    Bai, Yang (通讯)

  • W

    Wang, Jin (通讯)

    fourth mil med univ

  • M

    Ma, Li-Tian (通讯)

    fourth mil med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417